Cafepharma Today

February 11 2025 - Novartis inks $925M Anthos takeover to buy back phase 3 clot-busting candidate
Novartis inks $925M Anthos takeover to buy back phase 3 clot-busting candidate
Tariffs raise concern among generic drugmakers, as advocacy groups seek exemptions
Wegovy and Ozempic stars dim amid overuse concerns
Ten years on, Roche jettisons InterMune and Esbriet in US
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Me-Too Drugs: Are They Worth It?
Motley Fool
Thursday, August 28, 2008 - 5:06pm
tags:
Affymax, Takeda narrow Hematide focus
Bizjournals.com
Thursday, August 28, 2008 - 5:05pm
tags:
Buy! Sell! Analysts Duke It Out Over Amylin
WSJ Online
Thursday, August 28, 2008 - 5:02pm
tags:
The Vioxx ‘V’ Squad: Reps From Another Universe
Pharmalot
Thursday, August 28, 2008 - 5:00pm
tags:
Amylin Pharmaceuticals shares recover some sharp losses following new Byetta deaths
Yahoo/AP
Thursday, August 28, 2008 - 12:53pm
tags:
Valeant and GlaxoSmithKline enter worldwide collaboration agreement for retigabine
RTT News
Thursday, August 28, 2008 - 11:11am
tags:
Merck's Charm Offensive
CNBC
Thursday, August 28, 2008 - 11:10am
tags:
BDSI gets good news on drug, though approval is delayed
Bizjournals.com
Thursday, August 28, 2008 - 10:54am
tags:
J&J to appeal Razadyne patent ruling
Marketwatch
Thursday, August 28, 2008 - 10:53am
tags:
Ortho-McNeil Neurologics to Appeal Patent Ruling on RAZADYNE
Yahoo/AP
Thursday, August 28, 2008 - 9:21am
tags:
Report: Medicare Pays Too Much for Some New Generics
WSJ Online
Thursday, August 28, 2008 - 8:09am
tags:
Pfizer Is Worth Another Look
Seeking Alpha
Thursday, August 28, 2008 - 8:08am
tags:
Amgen to Stop Offering Discounts on Anemia Drug
New York Times, NY
Thursday, August 28, 2008 - 8:00am
tags:
CROs: The 'Big Pharma Effect'
Seeking Alpha
Thursday, August 28, 2008 - 7:58am
tags:
Amgen to discontinue discounts on anemia drug: report
Yahoo/Reuters
Thursday, August 28, 2008 - 6:33am
tags:
Boehringer Drugs Disappoint in Company-Sponsored Stroke Study
Bloomberg
Thursday, August 28, 2008 - 6:32am
tags:
UCB Cuts 2,000 Jobs to Spur Profit; Shares Decline
Bloomberg
Thursday, August 28, 2008 - 6:32am
tags:
Cell Genesys' Saving Grace
Forbes
Wednesday, August 27, 2008 - 10:30pm
tags:
Takeda's Velcade Found Better Than Standard Blood-Cancer Drug
Bloomberg
Wednesday, August 27, 2008 - 10:28pm
tags:
Efficacy Questions Still Dog Vytorin
Forbes
Wednesday, August 27, 2008 - 10:27pm
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

The Continuing NIH/NSF Crisis, Part III: Indirect Costs
In the Pipeline
Vaccines Through Protein Degradation
In the Pipeline
Today’s Rare Disease Launches Require the Right Specialty Pharmacy Partner
Drug Channels
An Evaluation of "Deep Research" Performance
In the Pipeline
The Continuing NIH/NSF Crisis, Part II
In the Pipeline
Revised and Extended: What's Happening Inside the NIH and NSF
In the Pipeline
What's Happening Inside the NIH and NSF
In the Pipeline
Vertical Integration Redux: How Pharmaceutical Wholesalers Are Transforming the Buy-and-Bill Market (Video)
Drug Channels
Informa Connect's Access USA
Drug Channels

Latest Jobs

Cell Therapy Navigator
Houston, Texas, 77002
Inizio Engage
Rapid Deployment Representative
Fort Worth, Texas, 76102
Inizio Engage
Rapid Deployment Representative
Charlotte, North Carolina, 28245
Inizio Engage
Oncology Key Account Manager
Newark, New Jersey, 07175
Inizio Engage
Cell Therapy Navigator
Little Rock, Arkansas, 72208
Inizio Engage
Territory Business Manager
Philadelphia, Pennsylvania, 19107
Inizio Engage
Business Development Representative
Las Vegas, Nevada, 89105
Professional Case Management
Oncology Key Account Manager
Atlanta, Georgia, 30383
Inizio Engage
Territory Manager, Surgical Pain - South Houston, TX
TX,
Avanos Medical
Neurology Account Manager- MD/DC/N VA (Remote)
Annapolis, Maryland, 21401
Jazz Pharmaceuticals
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information